D-dimer levels and 90-day outcome in patients with acute pulmonary embolism with or without cancer

Thrombosis Research

Volumn 133, Issue 3, 2014, Pages 384-389

  Maestre, Ana ^a   Trujillo Santos, Javier ^b   Visoná, Adriana ^c   Lobo, José Luís ^d   Grau, Enric ^e   Malý, Radovan ^f   Duce, Rita ^g   Monreal, Manuel ^h  

^a Hospital Vinalopo Salud   (Spain)

^b Complejo Hospitalario Universitario de Cartagena ^*  (Spain)

^c Ospedale Castel Franco TV   (Italy)

^d HOSPITAL TXAGORRITXU   (Spain)

^e HOSPITAL LLUÍS ALCANYÍS   (Spain)

^f UNIVERSITY HOSPITAL HRADEC KRALOVE   (Czech Republic)

^g GALLIERA HOSPITAL   (Italy)

^h HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; FIBRIN DEGRADATION PRODUCT; FIBRIN FRAGMENT D;

AGED; BLOOD; FEMALE; HUMAN; LUNG EMBOLISM; MALE; METABOLISM; NEOPLASM; PROGNOSIS; RISK FACTOR;

AGED; ANTICOAGULANTS; FEMALE; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; HUMANS; MALE; NEOPLASMS; PROGNOSIS; PULMONARY EMBOLISM; RISK FACTORS;

EID: 84893974598     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/j.thromres.2013.12.044     Document Type: Article

References (38)

1. S.Z. Goldhaber, L. Visani, and M. De Rosa Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER) Lancet 353 1999 1386 1389
2. D.J. Quinlan, A. McQuillan, and J.W. Eikelboom Low-molecular-weight heparin compared with intravenous unfractionated heparin for treatment of pulmonary embolism: a meta-analysis of randomized, controlled trials Ann Intern Med 140 2004 175 183
3. J.D. Douketis, S. Bates, E.K. Duku, and J.S. Ginsberg Risk of fatal pulmonary embolism in patients with treated venous thromboembolism JAMA 279 1998 458 462
4. C. Kearon, E.A. Akl, A.J. Comerota, P. Prandoni, H. Bounameaux, and S.Z. Goldhaber et al. American College of Chest Physicians. Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis American College of Chest Physicians Evidence-Based Clinical Practice Guidelines 9th ed. Chest 141 (2 Suppl.) 2012 419 494
5. D. Aujesky, D.S. Obrosky, R.A. Stone, T.E. Auble, A. Perrier, and J. Cornuz et al. A prediction rule to identify low-risk patients with pulmonary embolism Arch Intern Med 166 2006 169 175
6. D. Jiménez, D. Aujesky, L. Moores, V. Gómez, J.L. Lobo, and F. Uresandi et al. Simplification of the pulmonary embolism severity index for prognostication in patients with acute symptomatic pulmonary embolism Arch Intern Med 170 2010 1383 1389
7. U. Alehagen, U. Dahlstrom, and T.L. Lindahl Elevated D-dimer level is an independent risk factor for cardiovascular death in out-patients with symptoms compatible with heart failure Thromb Haemost 92 2004 1250 1258
8. A. Marcucci, A.M. Gori, F. Giannotti, M. Baldi, V. Verdiani, and S. Del Pace et al. Markers of hypercoagulability and inflammation predict mortality in patients with heart failure J Thromb Haemost 4 2006 1017 1022
9. N. Fiotti, A. Di Chiara, N. Altamura, M. Miccio, P. Fioretti, and G. Guarneri et al. Coagulation indicators in chronic stable effort angina and unstable angina: relationship with acute phase reactants and clinical outcome Blood Coagul Fibrinolysis 13 2002 247 255
10. I. Mahe, L. Drouet, G. Simoneau, S. Minh-Muzeaux, C. Caulin, and J.F. Bergmann D-dimer can predict survival in patients with chronic atrial fibrillation Blood Coagul Fibrinolysis 15 2004 413 417
11. J.M. Querol-Ribelles, J.M. Tenias, E. Grau, J.M. Querol-Borras, J.L. Climent, and E. Gomez et al. Plasma D-dimer levels correlate with outcomes in patients with community-acquired pneumonia Chest 126 2004 1087 1092
12. A.F. Shorr, R.F. Trotta, and S.A. Alkins D-dimer assay predicts mortality in critically ill patients without disseminated intravascular or venous thromboembolic disease Intensive Care Med 25 1999 207 210
13. L. Masotti, E. Ceccarelli, and R. Capelli Plasma D-dimer levels in elderly patients with suspected pulmonary embolism Thromb Res 98 2000 577 579
14. J. Walston, M.A. McBurnie, and A. Newman Frailty and activation of the inflammation and coagulation systems with and without clinical comorbidities: results from the Cardiovascular Health Study Arch Intern Med 162 2004 2333 2341
15. M. Righini, A. Perrier, P. De Moerloose, and H. Bournameaux D-Dimer for venous thromboembolism diagnosis: 20 years later J Thromb Haemost 6 2008 1059 1071
16. E. Grau, J.M. Tenias, M.J. Soto, M.R. Gutierrez, R. Lecumberri, and J.L. Pérez et al. D-dimer levels correlate with mortality in patients with acute pulmonary embolism: Findings from the RIETE registry Crit Care Med 35 2007 1937 1941
17. J.L. Lobo, V. Zorrilla, F. Aizpuru, E. Grau, D. Jimenez, and G. Palareti et al. D- dimer levels and 15-day outcome in acute pulmonary embolism. Findings from the RIETE Registry J Thromb Haemost 7 2009 1795 1801
18. D. Aujesky, P.M. Roy, M. Guy, J. Cornuz, O. Sanchez, and A. Perrier Prognostic value of D-dimer in patients with pulmonary embolism Thromb Haemost 96 2006 478 482
19. F.A. Klok, R.K. Djurabi, M. Nijkeuter, H.C.J. Eikenboom, F.W.G. Leebeek, and M.H.H. Kramer et al. High D-dimer level is associated with increased 15-d and 3 months mortality though a more central localization of pulmonary emboli and serious comorbidity Br J Haematol 140 2007 218 222
20. N. Vuilleumier, G. Le Gal, F. Verschuren, A. Perrier, H. Bounameaux, and N. Turck et al. Cardiac biomarkers for risk stratification in non-massive pulmonary embolism: a multicenter prospective study J Thromb Haemost 7 2009 391 398
21. J. Blamoun, M. Alfakir, A.R. Sedfawy, M.Q. Moammar, M. Maroules, and M.A. Khan et al. The association of D-dimer levels with clinical outcomes in patients presenting with acute pulmonary embolism Lab Hematol 15 2009 4 9
22. M.J. Agterof, E.R. van Bladel, R.E. Schutgens, R.J. Snijder, E.A. Tromp, and M.H. Prins et al. Risk stratification of patients with pulmonary embolism based on pulse rate and D-dimer concentration Thromb Haemost 102 2009 683 687
23. J.C. Yoon, W.Y. Kim, S.S. Choi, A.K. Jung, C.H. Sohn, and W. Kim et al. D-dimer as a prognostic tool in patients with normotensive pulmonary embolism Tuber Respir Dis 68 2010 87 92
24. T. Walter, P. Apfaltrer, F. Weilbacher, M. Meyer, S. Schoenberg, and C. Fink et al. Predictive value of high-sensitivity troponin I and D-dimer assays for adverse outcome in patients with acute pulmonary embolism Exp Ther Med 5 2013 586 590
25. R. Rydman, M. Soderberg, F. Larsen, M. Alam, and K. Caidahl D- dimer and simplified pulmonary embolism severity index in relation to right ventricular function Am J Emerg Med 31 2013 482 486
26. S. Paneesha, E. Cheyne, K. French, S. Bacchu, A. Borg, and P. Rose High D-dimer levels at presentation in patients with venous thromboembolism is a marker of adverse clinical outcomes Br J Haematol 135 2006 85 90
27. C. Becattini, A. Lignani, L. Masotti, M.B. Forte, and G. Agnelli D-dimer for risk stratification in patients with acute pulmonary embolism J Thromb Thrombolysis 33 2012 48 57
28. D. Ferrigno, G. Buccheri, and I. Ricca Prognostic significance of blood coagulation tests in lung cancer Eur Respir J 17 2001 667 673
29. R.E. Schutgen, M.M. Beckers, F.J. Haas, and D.H. Biesma The predictive value of D-dimer measurement for cancer in patients with deep vein thrombosis Haematologica 90 2005 214 219
30. S. Paneesha, E. Cheyne, K. French, J. Delgado, A. Borg, and P. Rose High D-dimer level at presentation in patients with venous thrombosis is a marker for malignancy Haematologica 90 2005 e87
31. H.K. Kim, K.S. Song, K.R. Lee, Y.H. Kang, Y.J. Lee, and E.S. Lee Comparison of plasma D-dimer and thrombus precursor protein in patients with operable breast cancer as a potential predictor of lymph node metastasis Blood Coagul Fibrinolysis 15 2004 9 13
32. M. Monreal, C. Falga, M. Valdes, C. Suarez, F. Gabriel, and C. Tolosa et al. Fatal pulmonary embolism and fatal bleeding in cancer patients with venous thromboembolism: findings from the RIETE Registry J Thromb Haemost 4 2006 1950 1956
33. N. Ruiz Gimenez, C. Suarez, R. Gonzalez, J.A. Nieto, J.A. Todoli, and A.L. Samperiz et al. Predictive variables for major bleeding events in patients presenting with documented acute venous thromboembolism. Findings from the RIETE Registry Thromb Haemost 100 2008 26 31
34. S. Laporte, P. Mismetti, H. Decousus, F. Uresandi, R. Otero, and J.L. Lobo et al. Clinical predictors for fatal pulmonary embolism in 15,520 patients with venous thromboembolism. Findings from the Registro Informatizado de la Enfermedad Tromboembolica venosa (RIETE) Circulation 117 2008 1711 1716
35. W. Nieuwenhuizen A reference material for harmonisation of D-dimer assays. Fibrinogen Subcommittee of the Scientific and Standardization Committee of the International Society of Thrombosis and Haemostasis Thromb Haemost 77 1997 1031 1033
36. E.J. Favaloro Standardization, regulation, quality assurance and emerging technologies in hemostasis: issues, controversies, benefits and limitations Semin Thromb Hemost 33 2007 290 297
37. C.E. Dempfle, S. Zips, H. Ergul, and D.L. Heene The Fibrin Assay Comparison Trial (FACT): evaluation of 23 quantitative D-dimer assays as basis for the development of D-dimer calibrators. FACT study group Thromb Haemost 85 2001 671 678
38. P. Meijer, F. Haverkate, C. Kluft, P. de Moerloose, B. Verbruggen, and M. Spannagl A model for the harmonisation of test results of different quantitative D-dimer methods Thromb Haemost 95 2006 567 572